| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MERIDIAN BIOSCIENCE INC | Exec VP & CFO | Common Stock | 60.9K | $1.24M | $20.38 | Dec 15, 2021 | Direct |
| MERIDIAN BIOSCIENCE INC | Exec VP & CFO | Stock Options (Right to Buy) | 11.7K | $155K | $13.25 | Nov 4, 2021 | Direct |
| InMed Pharmaceuticals Inc. | Director | Employee Stock Option (Right to Buy) | 8.5K | Dec 23, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| INM | InMed Pharmaceuticals Inc. | Dec 23, 2023 | 1 | $0 | 4 | Dec 26, 2023 | Director |
| INM | InMed Pharmaceuticals Inc. | Dec 16, 2022 | 1 | $0 | 4 | Dec 19, 2022 | Director |
| INM | InMed Pharmaceuticals Inc. | May 17, 2022 | 1 | $0 | 4 | May 19, 2022 | Director |
| INM | InMed Pharmaceuticals Inc. | May 12, 2022 | 0 | $0 | 3 | May 19, 2022 | Director |
| VIVO | MERIDIAN BIOSCIENCE INC | Dec 15, 2021 | 1 | -$35.6K | 4 | Dec 22, 2021 | Exec VP & CFO |
| VIVO | MERIDIAN BIOSCIENCE INC | Nov 15, 2021 | 1 | -$76.7K | 4 | Dec 16, 2021 | Exec VP & CFO |
| VIVO | MERIDIAN BIOSCIENCE INC | Nov 15, 2021 | 2 | $0 | 4 | Nov 16, 2021 | Exec VP & CFO |
| VIVO | MERIDIAN BIOSCIENCE INC | Nov 4, 2021 | 2 | $0 | 4 | Nov 8, 2021 | Exec VP & CFO |